::: Blood CME Center :::

Home/

News Feed

Blood CME Center News

“Uncontrolled Bleeding After Thoracic Aortic Aneurysm Repair: A Case Report and Interactive Discussion.” -Mark H. Ereth, MD
Treating Shock — Old Drugs, New Ideas
Fibrinogen and Perioperative Bleeding in Cardiac Surgery from the Blood CME Center
How Feasible Is Autologous Stem Cell Transplantation in Elderly Patients With Multiple Myeloma? Editor’s Spotlight
Fibrinogen Deficiency: A Fundamental Risk Factor for Cardiac Surgery
The Blood CME Center Develops New Program on Coagulopathy in Cardiac Surgery
Is Plasma Fibrinogen a Biomarker for Bleeding in Cardiovascular Surgery?
Practical Strategies for Managing Perioperative Anemia: Screening and Presurgical Treatment
“Q&A: Pressing Issues About Preoperative Anemia”
Anemia is a common condition in surgical patients and is independently associated with increased mortality.
“Evidence-based therapeutic options should be weighed before, during, and after surgical procedures in order to effectively manage perioperative anemia.” Lawrence T. Goodnough, MD
Are Your Patients at Risk for Blood Transfusions?
The Cardiovascular & Metabolic Health Foundation Adds CEnow™ Activity on Managing Perioperative Anemia to Its Programming
“Anemia is not an innocent bystander.” Aryeh Shander, MD, FCCM, FCCP
Bovine Thrombin Exposure: How Real Is the Risk?
The Cardiovascular & Metabolic Health Foundation Develops New Program on Topical Hemostatic Agents and the Controversies Surrounding Them
“Our goal as clinicians…is to provide patients a safe corridor between competing biologic forces…” Jeffrey H. Lawson, MD, PhD
Q&A With Dr. Aryeh Shander: Room Temperature Formulation of rVIIa
Is Stored Blood Bad Blood?
The Cardiovascular & Metabolic Health Foundation Expands Programming
“If the patient’s at risk of bleeding to death, everybody has to be on the same page.” -Richard P. Dutton, MD, MBA
How Do You Plan for Bleeding Episodes in Your Surgical Patients?
The Cardiovascular & Metabolic Health Foundation Adds Another CEnow™ Activity to Its Programming
“The future of this business is going to be figuring out how to use alternative hemostatic agents.”—Richard P. Dutton, MD, MBA
Stratifying a Patient’s Preoperative Risk for Bleeding
The Cardiovascular & Metabolic Health Foundation Hosts Program on Trauma-Related Coagulopathy
“We accept bleeding and clotting as part of our everyday business, and I’m not sure we have to live with that as a standard.”—Jeffrey H. Lawson, MD, PhD
What Do You Do Before You Transfuse?
The Cardiovascular & Metabolic Health Foundation Develops New Program on Achieving Optimal Hemostasis
“Blood transfusion is not harmless. It’s not chicken soup.”
How Do You Manage Excessive Bleeding in the OR?
The Cardiovascular & Metabolic Health Foundation Launches Visiting Faculty Series
“Hemorrhage and thrombosis . . . they’re probably both ends of the same biologic process. . .” Jeffrey H. Lawson, MD, PhD
Which 6 Patient Types Present the Greatest Risk for Surgical Coagulopathy?
Postgraduate Institute for Medicine Sponsors Comprehensive Educational Initiative on Operative Bleeding and Thrombosis
Hypercoagulability Is Part of the Yin/Yang of Hemostasis Management

Blood Hematology News

Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin

Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature

Platelet function in brown bear (Ursus arctos) compared to man

Normal levels of protein C and protein S tested in the acute phase of a venous thromboembolic event are not falsely elevated

Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry

The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?

Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes

A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case-control-study

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study

Log In


Username
Password
Remember me on this computer

Forgot Your Username?
Forgot Your Password?

Log In


Username
Password
Remember me on this computer

Forgot Your Username?
Forgot Your Password?


If you have previously registered, enter your e-mail address and we will e-mail your password to you.

E-mail

Forgot Your Username?

Your Username is your e-mail address. Try re-entering your Username with your full e-mail address. If you have recently changed your e-mail address or have more than one, please try all possible options. If this does not work, please contact customer support for assistance.

Warning

Thank you for participating in PeerPaths™. Please note that you may only apply for credit once. Upon completion of the final survey, there is no opportunity to earn additional credit. Do you wish to proceed?

Log In

Forgot Your Password?

Forgot Your Username?

News Feed

Log In

Forgot Your Password?

Forgot Your Username?

Warning